| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |